California Public Employees Retirement System Has $27.03 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

California Public Employees Retirement System cut its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 21.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 104,638 shares of the biotechnology company’s stock after selling 28,352 shares during the period. California Public Employees Retirement System owned about 0.14% of Axon Enterprise worth $27,031,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Sands Capital Management LLC raised its holdings in Axon Enterprise by 31.1% in the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock worth $519,823,000 after purchasing an additional 619,179 shares during the period. Wellington Management Group LLP raised its holdings in Axon Enterprise by 3.3% in the third quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock worth $389,229,000 after purchasing an additional 62,324 shares during the period. Bank of New York Mellon Corp increased its position in shares of Axon Enterprise by 28.3% during the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock worth $144,546,000 after acquiring an additional 160,359 shares in the last quarter. Westfield Capital Management Co. LP increased its position in shares of Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after acquiring an additional 451,350 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Axon Enterprise by 3.1% during the third quarter. Northern Trust Corp now owns 631,212 shares of the biotechnology company’s stock worth $125,605,000 after acquiring an additional 19,068 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AXON has been the subject of several research reports. Argus initiated coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They set a “buy” rating and a $380.00 price objective for the company. Morgan Stanley increased their price objective on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Wednesday. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday. Finally, JMP Securities raised their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 6th. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $314.91.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $308.23 on Friday. The firm has a 50 day moving average of $304.22 and a 200-day moving average of $261.92. The stock has a market capitalization of $23.26 billion, a PE ratio of 134.01 and a beta of 0.93. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. The company had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, equities research analysts predict that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.